Literature DB >> 22143233

Managing pulmonary embolism using prognostic models: future concepts for primary care.

Geert-Jan Geersing1, Ruud Oudega, Arno W Hoes, Karel G M Moons.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22143233      PMCID： PMC3281155          DOI： 10.1503/cmaj.110213

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  39 in total

1.  Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians.

Authors:  Amir Qaseem; Vincenza Snow; Patricia Barry; E Rodney Hornbake; Jonathan E Rodnick; Timothy Tobolic; Belinda Ireland; Jodi Segal; Eric Bass; Kevin B Weiss; Lee Green; Douglas K Owens
Journal:  Ann Fam Med       Date:  2007 Jan-Feb       Impact factor: 5.166

Review 2.  Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism.

Authors:  B A Hutten; M H Prins
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 3.  Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis.

Authors:  Simon McRae; Huyen Tran; Sam Schulman; Jeff Ginsberg; Clive Kearon
Journal:  Lancet       Date:  2006-07-29       Impact factor: 79.321

4.  D-dimer testing to determine the duration of anticoagulation therapy.

Authors:  Gualtiero Palareti; Benilde Cosmi; Cristina Legnani; Alberto Tosetto; Carlotta Brusi; Alfonso Iorio; Vittorio Pengo; Angelo Ghirarduzzi; Corrado Pattacini; Sophie Testa; Anthonie W A Lensing; Armando Tripodi
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

5.  Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Clive Kearon; Susan R Kahn; Giancarlo Agnelli; Samuel Goldhaber; Gary E Raskob; Anthony J Comerota
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

6.  The risk of recurrent venous thromboembolism in men and women.

Authors:  Paul A Kyrle; Erich Minar; Christine Bialonczyk; Mirko Hirschl; Ansgar Weltermann; Sabine Eichinger
Journal:  N Engl J Med       Date:  2004-06-17       Impact factor: 91.245

7.  Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy.

Authors:  David Jiménez; Roger D Yusen; Remedios Otero; Fernando Uresandi; Dolores Nauffal; Elena Laserna; Francisco Conget; Mikel Oribe; Miguel A Cabezudo; Gema Díaz
Journal:  Chest       Date:  2007-07       Impact factor: 9.410

8.  Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy.

Authors:  Marc A Rodger; Susan R Kahn; Philip S Wells; David A Anderson; Isabelle Chagnon; Grégoire Le Gal; Susan Solymoss; Mark Crowther; Arnaud Perrier; Richard White; Linda Vickars; Tim Ramsay; Marisol T Betancourt; Michael J Kovacs
Journal:  CMAJ       Date:  2008-08-26       Impact factor: 8.262

Review 9.  Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis.

Authors:  Frederikus A Klok; Inge C M Mos; Menno V Huisman
Journal:  Am J Respir Crit Care Med       Date:  2008-06-12       Impact factor: 21.405

10.  Prognostic value of troponins in acute pulmonary embolism: a meta-analysis.

Authors:  Cecilia Becattini; Maria Cristina Vedovati; Giancarlo Agnelli
Journal:  Circulation       Date:  2007-07-02       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.